DuPont de Nemours (DuPont) scored a 100 out of 100 on the 2023-2024 Corporate Equality Index (CEI) from the Human Rights Campaign (HRC), a political stakeholder group. By complying with the HRC’s controversial demands, DuPont increases the risk of dividing employees, alienating customers and harming shareholders. The company provides a benefits package for employees which covers transgender medical procedures for covered employees and dependents, including children. It also uses sex and gender ideology criteria in employee recruitment, vendor selection, marketing, and philanthropic support. DuPont forces employees to undergo multiple ideological trainings and uses its reputation, corporate funds, and political influence to support controversial sex and gender ideologies, organizations, and legislation. DuPont does not provide viewpoint protections for its employees. The company’s executive chairman and CEO signed Catalyst's Champions for Change pledge. DuPont supports the Equality Act and is a coalition partner of America Competes. The company signed an amicus brief in opposition to the 2016 North Carolina bathroom bill HB2, which required people to use the bathroom of their biological sex. Chemours former CEO, Mark Vergnano, signed the CEO Action for Diversity & Inclusion pledge, which includes a commitment to promote DEI through bias education training in the workplace. DuPont pledged $30 million to Black Lives Matter and related causes. DuPont CEO, Edward D. Breen, signed the CEO Action for Diversity & Inclusion pledge, which includes a commitment to promote DEI through bias education training in the workplace. The company is a brass sponsor of Out & Equal and a corporate partner of the National LGBT Chamber of Commerce (NGLCC). DuPont is a signatory of the Gender & Diversity KPI Alliance, appearing to prioritize diversity over merit in its business structure through the establishment of gender and racial targets for its leadership composition and its support of DEI in its hiring and promotions. For these reasons, DuPont receives a High Risk rating.